Protection from renal fibrosis, putative role of TRIB3 gene silencing

Wen-yuan Ding1, Wen-bo Li1, Yun Ti1

  • 1Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan 250012, PR China; Department of Cardiology, Qilu Hospital of Shandong University, Ji'nan 250012, PR China.

Abstract

Insights

Tribbles homolog 3 (TRIB3) overexpression drives renal fibrosis in insulin-resistant rats. Silencing TRIB3 ameliorates kidney fibrosis by reducing extracellular signal-regulated kinase (ERK) phosphorylation, offering a potential therapeutic target for chronic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Renal fibrosis is a common pathway in chronic kidney disease (CKD).
  • Tribbles homolog 3 (TRIB3) is implicated in cardiac fibrosis during insulin resistance.
  • The role of TRIB3 in renal fibrosis remains unclear.

Purpose of the Study:

  • To investigate the role of TRIB3 in the pathogenesis of renal fibrosis in insulin-resistant rats.
  • To determine if TRIB3 influences key signaling pathways involved in fibrosis.

Main Methods:

  • 40 male Sprague-Dawley rats were divided into control, high-fat diet (HFD), HFD with TRIB3 siRNA, and HFD with vehicle groups.
  • Insulin resistance markers were assessed.
  • Renal tissues were analyzed using histological staining (H&E, Masson's trichrome, PAS).

Main Results:

  • HFD induced insulin resistance and TRIB3 overexpression in rats.
  • TRIB3 upregulation correlated with renal fibrosis and increased extracellular signal-regulated kinase (ERK) phosphorylation.
  • TRIB3 siRNA knockdown attenuated renal fibrosis and decreased ERK phosphorylation.

Conclusions:

  • TRIB3 gene silencing effectively reduces renal fibrosis in a rat model of insulin resistance.
  • TRIB3 plays a significant role in the development of renal fibrosis.
  • Targeting TRIB3 may offer a therapeutic strategy for managing chronic kidney disease.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K